Biosurgery Market Overview, Analysis And Demand By 2034

Whether you're expanding or optimizing within the biosurgery industry, this report offers the clarity and context needed for confident decision-making.

What Is The Projected Market Size & Growth Rate Of The Biosurgery Market?
The biosurgery market size has grown strongly in recent years. It will grow from $15.27 billion in 2024 to $16.44 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing surgical procedures, rise in chronic diseases, growing geriatric population, shift towards biodegradable product, regulatory changes, and approvals.

The biosurgery market size is expected to see strong growth in the next few years. It will grow to $22.79 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to advancements in tissue engineering, rise in minimally invasive procedures, focus on regenerative medicine, shift towards biologics, aging population needs. Major trends in the forecast period include growth in minimally invasive procedures, rise in cosmetic and plastic surgeries, focus on stem cell therapies, advancements in wound care, development of biodegradable products.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9380&type=smp

What Is The Crucial Factor Driving The Global Biosurgery Market?
The increase in the prevalence of chronic disease is expected to propel the growth of the biosurgery market going forward. Chronic disease refers to health problems that persist for a year or longer and necessitate continuing medical care, restricting everyday activities, or both. The main causes of death and disability in the US are chronic diseases such as diabetes, cancer, and heart disease. Biosurgery is used to eliminate dead tissue, lower the risk of infection, and speed up the healing process for chronic wounds. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based self-contained legal agency responsible for collecting and analyzing data as well as making evidence-based recommendations to federal, state, and territory governments, seventy-eight percent (78.6%) of Australians suffered from at least one chronic illness. 11.6 million individuals, or over half of the population, suffered from at least one chronic illness. Therefore, the increase in the prevalence of chronic disease is driving the growth of the biosurgery market.

Segment Covered In The Biosurgery Market Report
The biosurgerymarket covered in this report is segmented –

1) By Product: Bone-Graft Substitutes; Soft-Tissue Attachments; Hemostatic Agents; Surgical Sealants And Adhesives; Adhesion Barriers; Staple Line Reinforcement
2) By Source: Natural Or Biologics Products; Synthetic Products
3) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Gynecological Surgery; Other Applications
4) By End-User: Hospitals; Clinics; Other End-Users

Subsegments:
1) By Bone-Graft Substitutes: Synthetic Bone Grafts; Natural Bone Grafts
2) By Soft-Tissue Attachments: Mesh Products; Biological Grafts
3) By Hemostatic Agents: Powdered Agents; Gel-based Agents
4) By Surgical Sealants And Adhesives: Fibrin Sealants; Synthetic Sealants
5) By Adhesion Barriers: Absorbable Barriers; Non-absorbable Barriers
6) By Staple Line Reinforcement: Reinforcement Devices; Surgical Staples

Key Trends Driving Growth In The Biosurgery Market
Major companies operating in the biosurgery market are leveraging advancements in technology, such as advanced wound care technology, to enhance healing outcomes, reduce infection rates, and improve patient recovery times through innovative products and techniques. Advanced wound care technology encompasses innovative methods and products designed to enhance wound healing, prevent infection, and improve patient outcomes. For instance, in September 2024, Health Care at Home India Pvt Ltd, an India-based company that manufactures medical products, launched WOW (Warriors of Woundcare) Nurses. The WOW Nurses initiative seeks to proactively prevent and treat bedsores, common complications for patients with limited mobility. Bedsores can significantly slow recovery, increase hospital stays, and elevate infection risk.

Key Player In The Biosurgery Market
Major companies operating in the biosurgery market include Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., CryoLife Inc., CSL Limited, Pfizer Inc., Zimmer Biomet Holdings Inc., Kuros Biosciences AG, Orthofix Medical Inc., Smiths & Nephew plc, Medtronic plc, Stryker Corp., Betatech Medical, Tissue Regenix Group plc, Aroa Biosurgery Ltd., Anika Therapeutics Inc., Arthrex Inc., B Braun Surgical SA, Biom'Up SA, Boston Scientific Corporation, Coloplast Corp., Cook Medical Inc., Endo International plc, Genzyme Corporation, Takeda Pharmaceutical Company Limited, Cerus Corporation

View the full biosurgery market report here:
https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

Global Biosurgery Market - Regional Insights:
North America was the largest region in the biosurgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in the biosurgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company